Jeremy Graff
Chief Tech/Sci/R&D Officer presso IMV INC.
Patrimonio netto: 5 368 $ in data 31/03/2024
Profilo
Jeremy R.
Graff is currently the Director at IN8bio, Inc., Chief Scientific Officer at IMV, Inc., and President & Chief Scientific Officer at Biothera, Inc. He previously served as President & Chief Scientific Officer at Biothera Pharmaceutical, Inc. from 2018 to 2020 and as Chief Development Officer & Senior VP-Research at Hibercell, Inc. He received his undergraduate degree from Thomas More University and his doctorate from the University of Kentucky.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IN8BIO, INC.
0.01% | 13/12/2023 | 4 549 ( 0.01% ) | 5 368 $ | 31/03/2024 |
IMV INC.
-.--% | 20/03/2023 | 0 ( -.--% ) | - $ | 31/12/2023 |
Posizioni attive di Jeremy Graff
| Società | Posizione | Inizio |
|---|---|---|
| IMV INC. | Chief Tech/Sci/R&D Officer | 14/06/2021 |
| IN8BIO, INC. | Director/Board Member | 01/05/2023 |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | President | - |
Precedenti posizioni note di Jeremy Graff
| Società | Posizione | Fine |
|---|---|---|
Biothera Pharmaceutical, Inc.
 Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | President | 01/06/2020 |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
Formazione di Jeremy Graff
| Thomas More University | Undergraduate Degree |
| University of Kentucky | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IMV INC. | Health Technology |
| IN8BIO, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Commercial Services |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | Health Services |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Jeremy Graff
